Nov 17 (Reuters) - U.S. Food & Drug Administration:
* Says approved remote feature for follow-up programming sessions for Nucleus Cochlear implant system through telemedicine platform
* Says granted the approval of the Nucleus Cochlear implant system to cochlear americas